Reduced folate carrier polymorphism (80A→G) and neural tube defects

European Journal of Human Genetics

Volumn 11, Issue 3, 2003, Pages 245-252

  De Marco, Patrizia ^a   Calevo, Maria Grazia ^a   Moroni, Anna ^a   Merello, Elisa ^a   Raso, Alessandro ^a   Finnell, Richard H ^b   Zhu, Huiping ^b   Andreussi, Luciano ^a   Cama, Armando ^a   Capra, Valeria ^a  

^a G GASLINI INSTITUTE   (Italy)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Folate metabolism; Methylenetetrahydrofolate reductase (MTHFR); NTD; Polymorphisms; Reduced folate carrier 1 (RFC 1)

Indexed keywords

ADENINE; ARGININE; FOLIC ACID; GUANINE; HISTIDINE; REDUCED FOLATE CARRIER;

ADULT; ALLELE; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EXON; FEMALE; FOLATE METABOLISM; FREQUENCY ANALYSIS; GENE ISOLATION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; ITALY; MALE; MULTIFACTORIAL INHERITANCE; NEURAL TUBE DEFECT; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; ALLELES; CARRIER PROTEINS; CHILD; FEMALE; HUMANS; ITALY; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MULTIFACTORIAL INHERITANCE; MUTATION; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; RISK FACTORS;

MAMMALIA;

EID: 0242669376     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200946     Document Type: Article

References (40)

1. Freisheim JH, Price EM, Ratnam M: Folate coenzyme and antifolate transport proteins in normal and neoplastic tissues. Adv Enzyme Regul 1989; 29: 13-26.
2. Goldman ID, Lichtenstein NS, Oliverio, VT: Carrier-mediated transport of the folic acid analogue, methotrexate, in L1210 leukemia. J Biol Chem 1988; 243: 5007-5017.
3. Henderson GB, Zevely EM: Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate. J Membr Biol 1985; 85: 263-268.
4. Matherly LH, Czajkowski CA, Angeles SM: Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res 1991; 51: 3420-3426.
5. Chello PL, Sirotnak FM, Dorick DM, Donsbach RC: Therapeutic relevance of differences in the structural specificity of the transport system for folate analogs in L1210 tumor cells and in isolated murine intestinal epithelial cells. Cancer Res 1977; 37: 4297-4303.
6. Moscow JA, Gong M, He R et al: Isolation of a gene encoding a human reduced folate carrier (RFC-1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 1995; 55: 3790-3794.
7. Murray RC, Williams FMR, Flintoff WF: Structural organization of the reduced folate carrier gene in Chinese hamster ovary cells. J Biol Chem 1996; 32: 19174-19179.
8. Zhao R, Russell RG, Wang Y et al: Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 2001; 13: 10224-10228.
9. Czeizel AE, Dudas I: Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
10. MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
11. Mills JL, McPartlin JM, Kirke PN et al: Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-151.
12. Whitehead AS, Gallagher P, Mills JL et al: A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-766.
13. Blom HJ: Mutated 5, 10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia. Eur J Pediatr 1998; 157: S131-S134.
14. Whitehead AS, Gallagher P, Mills JL et al: A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-766.
15. Ou CY, Stevenson RE, Brown VK et al: 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-614.
16. Papapetrou C, Linch SA, Burn J, Edwards YH: Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996; 348:58.
17. van der Put NMJ, Steegers-Theunissen RPM, Frosst P et al: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
18. van der Put NMJ, Gabreels F, Stevens EMB et al: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factors for neural-tube defects? Am J Hum Genet 1998; 62:1044-1051.
19. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
20. Friedman G, Goldschmidt N, Friedlander Y et al: A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999; 129: 1656-1661.
21. De Marco P, Calevo MG, Moroni A et al: Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002; 47: 319-324.
22. De Marco P, Moroni A, Merello E et al: Folic acid receptor alpha microconversion events: a new risk for neural tube defects?. Am J Med Genet 2000; 95: 216-223.
23. Trembath D, Sherbondy AL, Vandyke DC et al: Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology 1999; 59: 331-341.
24. Barber RC, Lammer EJ, Shaw GM, Greer KA, Finnell RH: The role of folate transport and metabolism in neural tube defects risk. Mol Genet Metab 1999; 66: 1-9.
25. Chango A, Emery-Fillon N, de Courcy GP et al: A polymorphism (G80→A) in the reduced folate carrier gene and its associations with folate status and homocyteinemia. Mol Genet Metab 2000; 70: 310-315.
26. De Marco P, Cavelo MG, Moroni A et al: Polymrphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 2001; 11 (Suppl I): 14-17.
27. Frosst P, Blom HJ, Milos R et al: A candidate genetic risk for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
28. van der Put NMJ, Blom HJ, Letter to Editor: Am J Hum Genet 2000; 66: 744-745.
29. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
30. Botto LD, Yang Q: 5,10-methylenetetrahydrofolac reducatase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000; 151: 862-877.
31. Isotallo PA, Wells GA, Donnelly JG: Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000; 67: 986-990.
32. Anthony AC: The biological chemistry of folate receptors. Blood 1992; 79: 2807-2820.
33. Heidkamper D, Muller V, Nelson DR, Klingenberg M: Probing the role of positive residues in the ADP/ATP carrier from yeast. The effect of six arginine mutations on transport and the four ATP versus ADP exchange models. Biochemistry 1996; 35: 16144-16152.
34. Karbach D, Staub M, Wood PG, Passow H: Effect of side-directed mutagenesis of the arginine residues 509 and 748 on mouse band 3 protein-mediated anion transport. Biochem Biophys Acta 1998; 1371:114-122.
35. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH: Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genetics 2002; 108: 1-6.
36. de Franchis R, Buoninconti A, Mandato C et al: The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 1998; 35: 1009-1013.
37. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A: Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina population. Eur J Pediatr 1998; 157: 487-492.
38. Mornet E, Muller F, Lenvoisé-Furet A et al: Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 1997; 100: 512-514.
39. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM: Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993; 86: 703-708
40. Molloy AM, Mills JL, Kirke PN et al: Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 1998; 78: 155-159.